Chinese Journal of Clinical Anatomy ›› 2019, Vol. 37 ›› Issue (3): 261-266.doi: 10.13418/j.issn.1001-165x.2019.03.005

Previous Articles     Next Articles

Effect of genistein on the number and function of HUVECs in preeclampsia patients and its mechanisms

LIU Li-xing 1 , MIN Xian-hui 2 , ZHANG Min 1, HOU Sai-rong1   

  1. 1. Department of Anatomy, Histology and Embryology, Basic Medical College of Putian University, Putian 351100, Fujian Province, China; 2. Department of Obstetrics and Gynecology, First Hospital Affiliated to Fuzhou General Hospital of Nanjing Military Command of PLA, Putian Fujian 351100, China 
  • Received:2019-03-23 Online:2019-05-25 Published:2019-06-13

Abstract: Objective To study the effect of genistein on endothelial cell damage in preeclampsia.  Methods Human umbilical vein cells (HUVECs) were isolated from 20 normal pregnant women (control group) and 40 preeclampsia patients. Half of cells from the preeclampsia patients were treated with genistein (PE+Gen group) and the other half were untreated (PE group). HUVEC barrier function and proliferation were investigated using bovine serum albumin and MTT assays, respectively. Markers for oxidative stress and apoptosis were also assessed.  Results Compared to the PE group, HUVEC barrier function, proliferation, glutathione peroxidase activity, and Bcl-2 gene and protein expression were significantly increased in the genistein treatment group (PE+Gen), whereas 8-hydroxy-2’-deoxyguanosine levels and Bax gene and protein expression were significantly decreased (P<0.01). There was no significant difference between PE+Gen and control groups. Conclusion Genistein reduces endothelial cell damage possibly through antioxidant and anti-apoptotic mechanisms, and it may be useful in preeclampsia prevention and treatment.

Key words:  , Genistein, Preeclampsia,  Human umbilical vein endothelial cells,  Oxidative stress, Anti-apoptosis

CLC Number: